FDA OKs glucose monitoring tool from Abbott

03/8/2012 | Endocrine Today

The FDA has approved Abbott's FreeStyle InsuLinx Blood Glucose Monitoring System, which aims to improve the way patients manage their diabetes. The technology includes an automated logbook to help users monitor blood glucose levels and insulin doses, among other features.

View Full Article in:

Endocrine Today

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC